Farmacia Hospitalaria
Farmacia Hospitalaria

Venous thromboembolic disease

enfermedad tromboembólica

Venous thromboembolic disease (VTD) is a disorder that includes deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE).

 

This is a serious medical problem characterized by the formation of a blood clot in a deep vein, usually in the lower leg, which can grow or become fragmented, interrupting normal blood circulation and causing several abnormalities.

 

Anyone can be affected by deep vein thrombosis (DVT), which can lead to serious health problems. The positive thing is that it can be prevented, and also be treated more effectively in its early stages.

 

Pulmonary embolism (PE) occurs when the clot breaks off and reached the lungs, through the bloodstream.

 

Post-thrombotic syndrome occurs when the thrombosed vein dilates and the blood stagnates, the leg expands and the skin may become ulcerated, becoming bluish with a tendency to swell.

 
 

 
 

  • Previous deep vein thrombosis or pulmonary embolism.
  • Slow blood circulation due to inactivity.
  • Having undergone surgery, experienced a fracture, or any injury that involves a deep vein.
  • Age
  • Pregnancy
  • Oncology Treatment
  • Central venous catheter in situ
  • Hereditary factors
  • Heart, lung, Crohn’s disease
  • Obesity

Deep vein thrombosis (DVT)
 

  • Localized pain
  • Oedema
  • Feeling of warmth and heaviness
  • Swelling or inflammation
  • Sensitivity to touch
  • Skin reddening

 
 
Pulmonary thromboembolism (PTE)
 

  • Shortness of breath, gasping for air, feeling of drowning
  • Fast breathing
  • Syncope
  • Chest pain or discomfort
  • Coughing up blood
  • Increased heart rate
  • Anticoagulants are the treatment of choice for venous thromboembolic disease. These drugs alter blood clotting to prevent thrombus formation and help to breakdown a clot if it has already formed.
  •  

  • Treatment consists of subcutaneous heparin followed by oral anticoagulation in cases where treatment needs to be prolonged. Traditional drugs are now being replaced by new oral anticoagulants such as dabigatran, rivaroxaban, apixaban and edoxaban, these offer the advantage of not requiring regular INR monitoring at a health centre or hospital. INR is the index that tells us how long it takes the blood to clot and is used to follow-up patients on treatment with Sintrom or warfarin.

 

Consultants

Tel.: +34 952 908 628
+34 609 148 799

952908898 Oncology
951829978 Diagnosis by imaging
951829947 Gynecology
952908897 Fertility
951829947 Physiotherapy

 

     

     

    I agree to receive e-mails with offers and news about this and other services. *

    YesNo

     

    Responsible: HC Hospitales, S.L. Purpose: Managing the appointment process. Sending you information by newsletter, upon your acceptance. Duration: The data is deleted once the information has been provided to you, unless you contract our services or request us to contact you in the future. With regard to the newsletter, the data is deleted when you unsubscribe from it. Recipients: We do not disclose your data to any other party. Rights: To access, rectify, and delete your data, as well as further rights explained in the additional information webpage: https://clientes.prodat.es/privacidad/MLG/HCMARBELLA

     

    Specialized Care

    Patient Services

    HC Professionals

    Subscribe to our newsletter

    Subscribe